Frontier Biotech announced that from August 7 to September 28, 2026, RONGJIAN LU, a shareholder holding 5% or more of the company's shares, reduced its holdings by 2,2179.63 million shares through centralized bidding transactions and 7970.54 million shares through bulk transactions, for a total of 3,0150.17 million shares. After this change in equity, Lu Rongjian's shareholding volume was 187.287.33 million shares, which fell from 5.8049% to 4.9999% of the company's total share capital, hitting the 1% and 5% integer scale marks. The current holdings reduction plan has not yet been implemented and is still in the process of being implemented.

Frontier Biotech announced that from August 7 to September 28, 2026, RONGJIAN LU, a shareholder holding 5% or more of the company's shares, reduced its holdings by 2,2179.63 million shares through centralized bidding transactions and 7970.54 million shares through bulk transactions, for a total of 3,0150.17 million shares. After this change in equity, the number of shares held by Lu Rongjian was 187.287.33 million shares, which fell from 5.8049% to 4.9999% of the company's total share capital, hitting the 1% and 5% integer scale marks. The current holdings reduction plan has not yet been implemented and is still in the process of being implemented.